Article ID Journal Published Year Pages File Type
3282219 Clinical Gastroenterology and Hepatology 2015 13 Pages PDF
Abstract
In phase 3 studies in Japan, lubiprostone increased the weekly average number of SBMs and increased the quality of life of patients with CIC. Clinical Trial Notification of the Japanese Regulatory Authorities: 20-3296 and 20-3300.
Related Topics
Health Sciences Medicine and Dentistry Gastroenterology
Authors
, , , , ,